Spliceosome-Associated microRNAs Signify Breast Cancer Cells and Portray Potential Novel Nuclear Targets.

Area of Science:

• Molecular Biology
• Cancer Research
• Epigenetics

Background:

• MicroRNAs (miRNAs) are known cytoplasmic gene expression regulators.
• Previous research has indicated the presence of miRNAs within the cell nucleus.
• The functional significance of nuclear miRNAs, particularly within the spliceosome fraction (SF), remains largely unexplored.

Purpose of the Study:

• To investigate cell-line specific miRNA profiles within the spliceosome fraction (SF) of human breast cancer cells.
• To identify novel nuclear miRNAs and their potential targets in breast cancer.
• To explore the role of SF-miRNAs in regulating gene expression and cell-cycle progression.

Main Methods:

• Comparative analysis of miRNA sequences in the SF of breast cancer cell lines (MCF-7, MDA-MB-231) and a non-tumorigenic cell line (MCF-10A).
• Identification and characterization of specific miRNAs, including miR-7704, within the SF.
• Investigation of the inverse expression relationship between miR-7704 and the lncRNA HAGLR.
• Functional assays to assess the impact of miR-7704 inhibition and overexpression on HAGLR expression and cell-cycle progression.

Main Results:

• MiRNA identity, levels, and pre-miRNA composition in the SF are cell-line specific.
• miR-7704, located overlapping the HAGLR lncRNA, showed inverse expression with HAGLR.
• Inhibition of miR-7704 led to increased HAGLR expression, suggesting HAGLR as a nuclear target.
• Elevated miR-7704 levels induced minor alterations in cell-cycle progression in MDA-MB-231 cells.
• Expression trends of abundant SF-miRNAs differed from cytoplasmic miRNAs and patient cohort data.

Conclusions:

• SF-miR-7704 functions as a tumor suppressor, with HAGLR as its nuclear target.
• The findings suggest that SF-miRNAs may regulate distinct targets compared to their cytoplasmic counterparts.
• Spliceosome fraction miRNAs represent a potentially significant, yet understudied, area for understanding and targeting cancerous cell states.